Released on: March 28, 2008, 4:55 pm

Press Release Author: GTCbio

Industry: Biotech

Press Release Summary: Dr. Hakim Djaballah, Director of High Throughput Screening
Core Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio's
3rd Assay Development & Screening Technologies Conference on June 5-6, 2008 in San
Francisco, CA. Dr. Djaballah will speak on successful applications of high content
assays using confocal microscopy.


Press Release Body: Dr. Hakim Djaballah, Director of High Throughput Screening Core
Facility at the Memorial Sloan Kettering Cancer Center will present at GTCbio's 3rd
Assay Development & Screening Technologies Conference on June 5-6, 2008 in San
Francisco, CA. Dr. Djaballah will speak on successful applications of high content
assays using confocal microscopy.

Traditional screening has long been associated with a one to one relationship
between target and measured compound activity per screened well; sometimes referred
to as "Low Content Screening". Recent advances in robotic driven microscopy based
imaging and in screening data acquisition and management systems have allowed Dr.
Djaballah and his group to perform multiparameter screens enabling on the fly
prioritization of hits, especially those with undesirable features independent of
phenotypic readouts. As a result, they can now have an "n" to one relationship
between target and measured compound activity per screened well, where n is the
number of parameters measured; this new concept is referred to as "High Content
Screening".
Dr. Djaballah will be presenting an ensemble of projects utilizing this new concept
and will discuss the advantages of high content assays for chemical and functional
genomic screens.

GTCbio\'s 3rd Assay Development and Screening Technologies conference will provide
attendees with critical information to utilize in the discovery and development of
assays, while keeping them informed about the latest screening technologies for both
high-throughput screening and high-content screening. Topics being covered include
cell based assays, high throughput screening, high content screening, in vitro
assays and screening, novel assay and screening technologies, and target validation.
For more information visit www.gtcbio.com.
ABOUT GTCbio
GTCbio organizes conferences specifically for the biomedical and biopharmaceutical
industries. Our goal is to facilitate the exchange of biopharmaceutical and
biomedical intelligence between industry leaders, academic and government
organizations, and the financial community.
GTCbio is a subsidiary of Global Technology Community, LLC, a privately held company
founded in 2002.
Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax, nina.tran@gtcbio.com


Web Site: http://www.gtcbio.com

Contact Details: Contact: GTCBIO (626) 256-6405, (626) 256-6460 fax,
nina.tran@gtcbio.com
434 W. Foothill Blvd.
Monrovia, CA 91016